Epidermoid Carcinoma of the Anal Canal

 

 Buy Article Permissions and Reprints

ABSTRACT

Anal cancers are rare tumors with only an expected 4000 new diagnoses in 2005. The majority of these are epidermoid or squamous cell cancers. Despite the rarity of this disease, great advances have been made in its understanding and treatment. The human papillomavirus (HPV), immunosuppression for solid organ transplantation, the human immunodeficiency virus (HIV), and sexual practices are changing the demographics of the disease from elderly women to young men who have sex with men and young women infected with HPV and HIV. The treatment of these malignancies was radically changed with Dr. Nigro's description in 1974 of the use of a nonoperative treatment strategy. Today, radiochemotherapy represents first-line therapy and the role of surgery has been largely relegated to that of salvage therapy for treatment failures of nonoperative management.

REFERENCES

• 1 Jemal A, Murray T, Ward E et al.. Cancer statistics 2005.  CA Cancer J Clin. 2005;  55 10-30
  CrossrefPubMedGoogle Scholar
• 2 Ryan D P, Compton C C, Mayer R J. Carcinoma of the anal canal.  N Engl J Med. 2000;  342 792-800
  CrossrefPubMedGoogle Scholar
• 3 Nguyen W, Beck D E. Epidermoid carcinoma of the anal canal.  Clin Colon Rectal Surg. 2002;  15 263-270
  PubMedGoogle Scholar
• 4 Greene FL, Page DL, Fleming ID, et al AJCC Cancer Staging Manual. American Joint Committee on Cancer. 6th ed. New York; Springer-Verlag 2002
  Google Scholar
• 5 Morson B C, Sobin L H. Histologic Typing of Intestinal Tumors. Geneva; World Health Organization 1976: 67-69
  Google Scholar
• 6 Jass J R, Sobin L H. Histologic Typing of Intestinal Tumors: World Health Organization. 2nd ed. New York; Springer-Verlag 1989: 41-47
  Google Scholar
• 7 Tung W, Nivatvongs S. Perianal and anal canal neoplasms. In: Gordon PH, Nivatvons S Principles and Practice of Surgery for the Colon, Rectum, and Anus. 2nd ed. Saint Louis; Quality Medical Publishing 1999: 401-417
  Google Scholar
• 8 Grinvalsky H T, Helwig E G. Carcinoma of the anorectal junction. I. Histologic considerations.  Cancer. 1956;  9 480-488
  PubMedGoogle Scholar
• 9 Daling J R, Weiss N S, Hislop T G et al.. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer.  N Engl J Med. 1987;  317 973-977
  CrossrefPubMedGoogle Scholar
• 10 Daling J R, Weiss N S, Klopfenstein L L, Cochran L E, Chow W H, Daifuku R. Correlates of homosexual behavior and the incidence of anal cancer.  JAMA. 1982;  247 1988-1990
  CrossrefPubMedGoogle Scholar
• 11 Peters R K, Mack T M. Patterns of anal carcinoma by gender and marital status in Los Angeles County.  Br J Cancer. 1983;  48 629-636
  PubMedGoogle Scholar
• 12 Broker T R, Botchan M. Papillomaviruses: retrospectives and prospectives.  Cancer Cells. 1986;  4 17-36
  PubMedGoogle Scholar
• 13 Palefsky J M, Holly E A, Gonzales J, Berline J, Ahn D K, Greenspan J S. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer.  Cancer Res. 1991;  51 1014-1019
  PubMedGoogle Scholar
• 14 Shroyer K R, Kim J G, Manos M M, Greer C E, Pearlman N W, Franklin W A. Papillomavirus found in anorectal squamous carcinoma, not in colon adenocarcinoma.  Arch Surg. 1992;  127 741-744
  PubMedGoogle Scholar
• 15 Frisch M, Glimelius B, van den Brule A J et al.. Sexually transmitted infection as a cause of anal cancer.  N Engl J Med. 1997;  337 1350-1358
  CrossrefPubMedGoogle Scholar
• 16 Howley P M. On human papillomaviruses.  N Engl J Med. 1986;  315 1089-1090
  PubMedGoogle Scholar
• 17 Duggan M A, Boras V F, Inoue M, McGregor S E, Robertson D I. Human papillomavirus DNA determination of anal condylomata, dysplasias, and squamous carcinomas with in situ hybridization.  Am J Clin Pathol. 1989;  92 16-21
  PubMedGoogle Scholar
• 18 Williams G R, Lu O L, Love S B, Talbot I C, Northover J M. Properties of HPV-positive and HPV-negative anal carcinomas.  J Pathol. 1996;  180 378-382
  PubMedGoogle Scholar
• 19 Holly E A, Whittemore A S, Aston D A, Ahn D K, Nickoloff B J, Kristiansen J J. Anal cancer incidence: genital warts, anal fissure or fistula, hemorrhoids, and smoking.  J Natl Cancer Inst. 1989;  81 1726-1731
  PubMedGoogle Scholar
• 20 Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark.  BMJ. 1993;  306 419-422
  PubMedGoogle Scholar
• 21 Melbye M, Rabkin C, Frisch M, Biggar R J. Changing patterns of anal cancer incidence in the United States, 1940-1989.  Am J Epidemiol. 1994;  139 772-780
  PubMedGoogle Scholar
• 22 Kiviat N, Rompalo A, Bowden R et al.. Anal human papillomavirus infection among human immunodeficiency virus-seropositive and -seronegative men.  J Infect Dis. 1990;  162 358-361
  PubMedGoogle Scholar
• 23 Williams A B, Darragh T M, Vranizan K, Ochia C, Moss A R, Palefsky J M. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women.  Obstet Gynecol. 1994;  83 205-211
  PubMedGoogle Scholar
• 24 Palefsky J M, Holly E A, Hogeboom C J et al.. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men.  J Acquir Immune Defic Syndr Hum Retrovirol. 1998;  17 314-319
  CrossrefPubMedGoogle Scholar
• 25 Melbye M, Cote T R, Kessler L, Gail M, Biggar R J. High incidence of anal cancer among AIDS patients.  Lancet. 1994;  343 636-639
  CrossrefPubMedGoogle Scholar
• 26 Selik R M, Rabkin C S. Cancer death rates associated with human immunodeficiency virus infection in the United States.  J Natl Cancer Inst. 1998;  90 1300-1302
  CrossrefPubMedGoogle Scholar
• 27 Rabkin C S, Yellin F. Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.  J Natl Cancer Inst. 1994;  86 1711-1716
  PubMedGoogle Scholar
• 28 Goedert J J, Cote T R, Virgo P et al.. Spectrum of AIDS-associated malignant disorders.  Lancet. 1998;  351 1833-1839
  CrossrefPubMedGoogle Scholar
• 29 Frisch M, Biggar R J, Engels E A, Goedert J J. Association of cancer with AIDS-related immunosuppression in adults.  JAMA. 2001;  285 1736-1745
  CrossrefPubMedGoogle Scholar
• 30 Bower M, Powles T, Newsom-Davis T et al.. HIV-associated anal cancer. Has highly active antiretroviral therapy reduced the incidence or improved the outcome?.  J Acquir Immune Defic Syndr. 2004;  37 1563-1565
  CrossrefPubMedGoogle Scholar
• 31 Frisch M, Biggar R J, Goedert J J. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome.  J Natl Cancer Inst. 2000;  92 1500-1510
  PubMedGoogle Scholar
• 32 Penn I. Cancers of the anogenital region in renal transplant recipients: analysis of 65 cases.  Cancer. 1986;  58 611-616
  CrossrefPubMedGoogle Scholar
• 33 Arends M J, Benton E C, McLaren K M, Stark L A, Hunter J A, Bird C C. Renal allograft recipients with high susceptibility to cutaneous malignancy have an increased prevalence of human papillomavirus DNA in skin tumours and a greater risk of anogenital malignancy.  Br J Cancer. 1997;  75 722-728
  CrossrefPubMedGoogle Scholar
• 34 Holmes F, Borek D, Owen-Kummer M et al.. Anal cancer in women.  Gastroenterology. 1988;  95 107-111
  PubMedGoogle Scholar
• 35 Daling J R, Sherman K J, Hislop T G et al.. Cigarette smoking and the risk of anogenital cancer.  Am J Epidemiol. 1992;  135 180-189
  PubMedGoogle Scholar
• 36 Buckwalter J A, Jurayi M N. Relationship of chronic anorectal disease to carcinoma.  Arch Surg. 1957;  75 352-361
  PubMedGoogle Scholar
• 37 Kline R J, Spencer R J, Harrison Jr E G. Carcinoma associated with fistula-in-ano.  Arch Surg. 1964;  89 989-994
  PubMedGoogle Scholar
• 38 Frisch M, Olsen J H, Bautz A, Melbye M. Benign anal lesions and the risk of anal cancer.  N Engl J Med. 1994;  331 300-302
  CrossrefPubMedGoogle Scholar
• 39 Boman B M, Moertel C G, O'Connell M J et al.. Carcinoma of the anal canal: a clinical and pathologic study of 188 cases.  Cancer. 1984;  54 114-125
  CrossrefPubMedGoogle Scholar
• 40 Pintor M P, Northover J M, Nicholls R J. Squamous cell carcinoma of the anus at one hospital from 1948 to 1984.  Br J Surg. 1989;  76 806-810
  CrossrefPubMedGoogle Scholar
• 41 Schlienger M, Krzisch C, Pene F et al.. Epidermoid carcinoma of the anal canal treatment results and prognostic variables in a series of 242 cases.  Int J Radiat Oncol Biol Phys. 1989;  17 1141-1151
  PubMedGoogle Scholar
• 42 Touboul E, Schlienger M, Buffat L et al.. Epidermoid carcinoma of the anal canal: results of curative-intent radiation therapy in a series of 270 patients.  Cancer. 1994;  73 1569-1579
  PubMedGoogle Scholar
• 43 Nigro N D, Vaitkevicius V K, Considine Jr B. Combined therapy for cancer of the anal canal: a preliminary report.  Dis Colon Rectum. 1974;  17 354-356
  CrossrefPubMedGoogle Scholar
• 44 Beahrs O H, Wilson S M. Carcinoma of the anus.  Ann Surg. 1976;  184 422-428
  PubMedGoogle Scholar
• 45 Pocard M, Tiret E, Nugent K, Dehni N, Pare R. Results of salvage abdominoperineal resection for anal cancer after radiotherapy.  Dis Colon Rectum. 1998;  41 1488-1493
  PubMedGoogle Scholar
• 46 Klas J V, Rothenberger D A, Wong W D, Madoff R D. Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.  Cancer. 1999;  85 1686-1693
  CrossrefPubMedGoogle Scholar
• 47 Allal A S, Laurencet F M, Reymond M A, Kurtz J M, Marti M C. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment.  Cancer. 1999;  86 405-409
  CrossrefPubMedGoogle Scholar
• 48 Nilsson P J, Svensson C, Goldman S, Glimelius B. Salvage abdominoperineal resection in anal epidermoid cancer.  Br J Surg. 2002;  89 1425-1429
  CrossrefPubMedGoogle Scholar
• 49 Renehan A G, Saunders M P, Schofield P F, O'Dwyer S T. Patterns of local disease failure and outcome after salvage surgery in patients with anal cancer.  Br J Surg. 2005;  92 605-614
  CrossrefPubMedGoogle Scholar
• 50 Touboul E, Schlienger M, Buffat L et al.. Epidermoid carcinoma of the anal canal: results of curative-intent radiation therapy in a series of 270 patients.  Cancer. 1994;  73 1569-1579
  PubMedGoogle Scholar
• 51 Hughes L L, Rich T A, Delclos L, Ajani J A, Martin R G. Radiotherapy for anal cancer: experience from 1979-1987.  Int J Radiat Oncol Biol Phys. 1989;  17 1153-1160
  PubMedGoogle Scholar
• 52 Leichman L, Nigro N, Vaitkevicius V K et al.. Cancer of the anal canal: model for preoperative adjuvant combined modality therapy.  Am J Med. 1985;  78 211-215
  CrossrefPubMedGoogle Scholar
• 53 UKCCCR Anal Cancer Trial Working Party . Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin.  Lancet. 1996;  348 1049-1054
  CrossrefPubMedGoogle Scholar
• 54 Bartelink H, Roelofsen F, Eschwege F et al.. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups.  J Clin Oncol. 1997;  15 2040-2049
  PubMedGoogle Scholar
• 55 Flam M, John M, Pajak T F et al.. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study.  J Clin Oncol. 1996;  14 2527-2539
  PubMedGoogle Scholar
• 56 Rotman M, Lange C S. Anal cancer: radiation and concomitant continuous infusion chemotherapy.  Int J Radiat Oncol Biol Phys. 1991;  21 1385-1387
  PubMedGoogle Scholar
• 57 Bottomley D M, Aqel N, Selvaratnam G, Phillips R H. Epidermoid anal cancer in HIV infected patients.  Clin Oncol (R Coll Radiol). 1996;  8 319-322
  CrossrefPubMedGoogle Scholar
• 58 Cleator S, Fife K, Nelson M et al.. Treatment of HIV-associated invasive anal cancer with combined chemoradiation.  Eur J Cancer. 2000;  36 754-758
  CrossrefPubMedGoogle Scholar
• 59 Hocht S, Wiegel T, Kroesen A J et al.. Low acute toxicity of radiotherapy and radiochemotherapy in patients with cancer of the anal canal and HIV-infection.  Acta Oncol. 1997;  36 799-802
  PubMedGoogle Scholar
• 60 Kim J, Sarani B, Orkin B et al.. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients.  Dis Colon Rectum. 2001;  44 1496-1502
  CrossrefPubMedGoogle Scholar
• 61 Hoffman R, Welton M L, Klencke B, Weinberg V, Krieg R. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer.  Int J Radiat Oncol Biol Phys. 1999;  44 127-131
  CrossrefPubMedGoogle Scholar
• 62 Peddada A V, Smith D E, Rao A R, Frost D B, Kagan A R. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal.  Int J Radiat Oncol Biol Phys. 1997;  37 1101-1105
  CrossrefPubMedGoogle Scholar
• 63 Akbari R P, Paty P B, Guillem J G et al.. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy.  Dis Colon Rectum. 2004;  47 1136-1144
  CrossrefPubMedGoogle Scholar

Matthew G MutchM.D. 

Section of Colon and Rectal Surgery, Department of Surgery, Washington University School of Medicine

660 S. Euclid Ave., Box 8109, St. Louis, MO 63110-1010

Email: mutchm@wudosis.wustl.edu